JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease.
暂无分享,去创建一个
Pasko Rakic | Richard A Flavell | E. Hirsch | P. Rakic | M. Vila | R. Flavell | S. Przedborski | S. Hunot | Stéphane Hunot | Miquel Vila | Peter Teismann | Roger J Davis | Etienne C Hirsch | Serge Przedborski | P. Teismann | R. Davis
[1] M. Ross,et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] AC Tose. Cell , 1993, Cell.
[3] W. Tatton,et al. Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.
[4] M. Herkenham,et al. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic study , 1991, Neuroscience.
[5] A. Członkowska,et al. Indomethacin protects against neurodegeneration caused by MPTP intoxication in mice. , 2002, International immunopharmacology.
[6] Elan D. Louis,et al. Merritt's Neurology , 2001 .
[7] Ted M. Dawson,et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease , 1999, Nature Medicine.
[8] M. Kumegawa,et al. Fluid Shear Stress-induced Cyclooxygenase-2 Expression Is Mediated by C/EBP β, cAMP-response Element-binding Protein, and AP-1 in Osteoblastic MC3T3-E1 Cells* , 2001, The Journal of Biological Chemistry.
[9] H. Herschman,et al. Identification of multiple cis‐acting elements mediating the induction of prostaglandin G/H synthase‐2 by phorbol ester in murine osteoblastic cells , 2000, Journal of cellular biochemistry.
[10] T. Herdegen,et al. c-Jun N-Terminal Protein Kinase (JNK) 2/3 Is Specifically Activated by Stress, Mediating c-Jun Activation, in the Presence of Constitutive JNK1 Activity in Cerebellar Neurons , 2002, The Journal of Neuroscience.
[11] L. Mucke,et al. Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] E. Wagner,et al. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation , 1999, Nature Genetics.
[13] Dong-Kug Choi,et al. Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Miller,et al. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. , 1999, The Journal of pharmacology and experimental therapeutics.
[15] P. Rakic,et al. The Jnk1 and Jnk2 Protein Kinases Are Required for Regional Specific Apoptosis during Early Brain Development , 1999, Neuron.
[16] L. Wodicka,et al. Regional and strain-specific gene expression mapping in the adult mouse brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Garavito,et al. Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.
[18] D. Wilkin,et al. Neuron , 2001, Brain Research.
[19] Peter T Lansbury,et al. Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in cell biology.
[20] W. Dauer,et al. Parkinson's Disease Mechanisms and Models , 2003, Neuron.
[21] P. Lansbury,et al. Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in genetics & development.
[22] Y Agid,et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] David Baltimore,et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.
[24] M. Vila,et al. The role of glial cells in Parkinson's disease , 2001, Current opinion in neurology.
[25] J. Uney,et al. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] E. López-Martín,et al. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism , 1998, Journal of Neuroscience Methods.
[27] J. Mestre,et al. Redundancy in the Signaling Pathways and Promoter Elements Regulating Cyclooxygenase-2 Gene Expression in Endotoxin-treated Macrophage/Monocytic Cells* , 2001, The Journal of Biological Chemistry.
[28] M. Beal. Mechanisms of excitotoxicity in neurologic diseases , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Dirk Bohmann,et al. Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases , 1997, Science.
[30] E. Wagner,et al. The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brain. , 2002, Biochemical pharmacology.
[31] G. Pasinetti,et al. Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions , 1998, Journal of neuroscience research.
[32] R. Burke,et al. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[33] P. Rakic,et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene , 1997, Nature.
[34] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.